RUNX family members are DNA-binding transcription factors that regulate the expression of genes involved in cellular differentiation and cell cycle progression. The RUNX family includes three mammalian RUNX proteins (RUNX1, -2, -3) and two homologues in Drosophila. Experiments in Drosophila and mouse indicate that the RUNX proteins are required for gene silencing of engrailed and CD4, respectively. RUNX-mediated repression involves recruitment of corepressors such as mSin3A and Groucho as well as histone deacetylases. Furthermore, RUNX1 and RUNX3 associate with SUV39H1, a histone methyltransferase involved in gene silencing. RUNX1 is frequently targeted in human leukemia by chromosomal translocations that fuse the DNA-binding domain of RUNX1 to other transcription factors and corepressor molecules. The resulting leukemogenic fusion proteins are transcriptional repressors that form stable complexes with corepressors, histone deacetylases and histone methyltransferases. Thus, transcriptional repression and gene silencing through RUNX1 contribute to the mechanisms of leukemogenesis of the fusion proteins. Therapies directed at the associated cofactors may be beneficial for treatment of these leukemias.
Introduction
RUNX family members were initially implicated in transcriptional activation, and indeed these factors bind to core elements of enhancers and promoters that are required for the activation of a large number of genes. RUNX proteins bind DNA as heterodimers with core binding factor b (CBFb), a non-DNA-binding subunit that increases the affinity of RUNX factors for DNA (Ogawa et al., 1993; Wang et al., 1993) . The RUNX proteins are poor activators on their own, even though they are able to interact with transcriptional coactivators such as histone acetyltransferases. However, when placed in the appropriate context, RUNX family members act as organizing factors at the promoters and enhancers of target genes where they associate with cofactors and other DNA-binding transcription factors that are required for gene regulation. These factors include C/EBPa (Zhang et al., 1996; Westendorf et al., 1998) , ETS family members (Giese et al., 1995; Petrovick et al., 1998; Kim et al., 1999; Mao et al., 1999) , SMADs (Hanai et al., 1999; Gu et al., 2000; Jakubowiak et al., 2000; Pardali et al., 2000; Zhang and Derynck, 2000) and histone acetyltransferases including p300/CBP (Kitabayashi et al., 1998; Pelletier et al., 2002) .
In contrast, the RUNX proteins are potent repressors of transcription even when expressed alone, suggesting that their default function may be one of transcriptional repression. RUNX family members are required in vivo for gene silencing of the CD4 promoter in mice and of engrailed in Drosophila, which are among the best target genes elucidated to date. This review focuses on the mechanisms of RUNX-dependent transcriptional repression.
Runt-mediated gene silencing
The founding member of this gene family is runt, a Drosophila pair-rule gene that controls segmentation in the Drosophila embryo and plays important roles in neurogenesis and sex determination (reviewed in Canon and Banerjee, 2000) . Thus, the effects of runt expression and mutation can be studied by observing the resulting segmentation patterns of the Drosophila embryo. engrailed is a segment polarity gene that is potently repressed by Runt in the gastrula and germband extension stages of embryogenesis. Using an inducible runt, even moderate levels of Runt led to constitutive repression of engrailed and embryonic lethality (Wheeler et al., 2002) . Taking advantage of these phenotypes, a genetic screen was performed for factors that are required for repression by Runt.
Four proteins had dose-dependent effects on Runtmediated repression in this assay. These included Tramtrack (Ttk), a DNA-binding transcriptional repressor, the transcriptional corepressors dCtBP and Groucho, and the histone deacetylase Rpd3 (Wheeler et al., 2002) . Embryos that were derived from females heterozygous for tramtrack restored engrailed expression in the gastrula stage in the presence of ectopic Runt. In contrast, those that were derived from females expressing mutant Groucho and Rpd3 showed repression of engrailed mRNA in the gastrula stage but did not maintain this repression during germband extension. Rpd3 was not required for establishment of engrailed repression by Runt; however, maintenance of repression in the germband extension stage was sensitive to decreased Rpd3 activity. Recruitment of Groucho was not necessary for Runt-mediated repression at the blastoderm stage but was required for maintenance of this repression during germband extension (Wheeler et al., 2002) . Thus, there is a distinction between establishment and maintenance of Runt-dependent repression.
Unexpectedly, DNA binding was not required for Runt to cooperate with Ttk (Wheeler et al., 2002) . Thus, Runt may also be capable of functioning as a corepressor for Ttk and may be recruited by Ttk to the promoters of Ttk-regulated genes to repress transcription in the gastrula stage. However, maintenance of repression requires DNA binding of Runt at the promoter and further recruitment of the Groucho/ Rpd3 complex (Wheeler et al., 2002) . Rpd3 likely prevents activation through its histone deacetylase activity, which alters the local chromatin structure and thwarts access to activating factors and transcriptional initiation machinery.
Runx-mediated gene silencing in mice
RUNX factors are also required for gene silencing in mice. CD4 is a T-cell surface antigen that is a marker of thymocyte differentiation. Thymocyte differentiation involves several distinct steps that are marked by expression of the cell surface markers CD4 and CD8. Hematopoietic precursors differentiate into doublenegative thymocytes (CD4ÀCD8À), progress through a double-positive stage (CD4 þ CD8 þ ), and are selected for either CD4 or CD8 expression by silencing of one of these genes ( Figure 1 ). These single-positive thymocytes exit the thymus and have distinct actions in the periphery as CD4 þ helper cells or CD8 þ cytotoxic T cells. Mutagenesis of the regulatory element required for CD4 silencing during T-cell development identified two Runx consensus DNA-binding sites as required sequences, and Runx1 bound to both motifs (Taniuchi et al., 2002) . Chimeric mice containing mutations in the primary Runx binding site within the core sequence had variegated derepression of CD4 in 18-30% of mature CD8 þ T cells. Furthermore, mutation of the second Runx binding site resulted in full derepression of CD4 in these cells. Mutation of the two binding sites also resulted in partial derepression of CD4 in doublenegative thymocytes. Runx1 and Runx3, when fused to the GAL4 DNA-binding domain, were also able to actively repress transcription of a reporter in which the Runx binding site in the silencer core sequence was replaced by the GAL4 DNA-binding site (Taniuchi et al., 2002) .
The essential role of RUNX family proteins in CD4 silencing was demonstrated genetically. As deletion of the Runx genes can cause embryonic or neonatal lethality (Okuda et al., 1996; Wang et al., 1996; Komori et al., 1997; Li et al., 2002) , T cells were analysed in mice reconstituted with hematopoietic stem cells from the fetal livers of embryos lacking the Runx genes (2 and 3) or by using conditional recombination to remove Runx1. When immunodeficient mice lacking the recombinase Rag2 were reconstituted with fetal liver cells from Runx3 À/À mice, CD4 was derepressed in the peripheral cytotoxic T cells (Taniuchi et al., 2002) . Similar results were obtained using a strain of Runx3 knockout mice that are viable for several months (Levanon et al., 2002) . These mice displayed reduced numbers of CD8 þ T cells in the thymus and in the circulating T-cell population along with increased expression of CD4 in the peripheral CD8 þ cells (Woolf et al., 2003) . In contrast, mice that were reconstituted with fetal liver cells from Runx2 À/À mice displayed normal CD4 and CD8 expression on peripheral T cells (Taniuchi et al., 2002) . Thus, Runx3, but not Runx2, is required for the establishment of CD4 silencing in the progression from double-positive to single-positive T cells (Figure 1) .
Normal CD4 silencing was observed in peripheral CD8 þ T cells when Runx1 was removed from the T cells of mice using Cre recombinase expressed from the Lck promoter (Taniuchi et al., 2002) . However, more studies are needed to examine the function of Runx1 in peripheral T cells given that a large percentage of Figure 1 Runx1 and Runx3 are required for CD4 silencing in vivo. Runx1 binds the CD4 silencer and is required to repress transcription in immature double-negative (DN) thymocytes. Runx1 is also required for activation of CD8 as the DN population progresses into double-positive (DP) thymocytes. Runx3 establishes epigenetic silencing in CD4ÀCD8 þ cytotoxic T cells by binding the CD4 silencer core sequence. Runx1 may also be involved in CD4 silencing in CD8 þ T cells splenocytes retained Runx1 expression. In contrast, a role for Runx1 in double-negative thymocyte maturation was elucidated. The lack of Runx1 resulted in upregulation of CD4 expression in a TCRb lo immature thymocyte population (Taniuchi et al., 2002) . These results were similar to that of mice with deletions of the Runx binding sites in the CD4 silencer sequence. The mice displayed low numbers of total thymocytes and a higher percentage of thymocytes with low or absent expression of CD8 (Taniuchi et al., 2002) . In addition, haploinsufficiency of Runx1 in Runx3 null mice resulted in complete loss of CD8 þ T cells due to CD4 derepression in these cells (Woolf et al., 2003) . Thus, Runx1 cooperates with Runx3 to regulate T-cell development through CD4 silencing, and Runx1 is required for CD4 silencing in double-negative thymocytes (Figure 1 ).
Mechanisms of repression
Insights into the mechanisms of repression by RUNX family members have been derived from analogies to Drosophila corepressors and from studies of chromosomal translocation fusion proteins that affect RUNX1. Repression and activation by RUNX family members is cell-type specific and depends on associated cofactors. One of the first corepressors that was found to bind to RUNX factors is the human Groucho homologue TLE (Aronson et al., 1997; Imai et al., 1998; Javed et al., 2000) . The associations between RUNX factors and Groucho/TLE are relatively weak in that they were observed only in yeast two-hybrid and in vitro assays. In addition, Groucho-independent mechanisms of repression were identified (Aronson et al., 1997) . Therefore, Groucho/TLE family members may be promoterspecific corepressors for the RUNX factors.
The identification of other corepressors and histone deacetylases (HDACs) that are recruited by RUNX family members was based on studies of the chromosomal translocation fusion proteins that retain a portion of RUNX1. The t(8;21) fusion protein recruits mSin3A and mSin3B through at least two domains encoded by the gene from chromosome 8 known as ETO or MTG8 (Lutterbach et al., 1998; Amann et al., 2001) . Mutagenesis studies indicated that RUNX1 could also associate with mSin3A. Indeed, endogenous RUNX1 copurified with mSin3A in cells that were metabolically labeled and immunoprecipitated with an antibody directed to endogenous mSin3A (Lutterbach et al., 2000) . RUNX2 and RUNX3 also coimmunoprecipitated with mSin3 ( Figure 2) . The mSin3 interaction domain of RUNX1 was mapped to the region just C-terminal to the Runt homology domain as deletion of amino acids (aa) 208-237 impaired the association. Studies on the transcriptional activity of RUNX proteins in NIH3T3 cells indicated that RUNX1 repressed transcription in these cells. For example, the p21 waf1/cip1 promoter contains four perfect RUNX1 DNA-binding sites and was potently repressed by Runx1 (Lutterbach et al., 2000) . Removal of the Groucho binding domain in RUNX1 did not impair repression in this assay. In contrast, a deletion that impaired the recruitment of mSin3A ablated repression of the p21 promoter by RUNX1 (Lutterbach et al., 2000) . mSin3A recruits histone deacetylases (Laherty et al., 1997) , and treatment of RUNX1-expressing NIH3T3 cells with a broad-spectrum histone deacetylase inhibitor, Trichostatin A, impaired repression by RUNX1 implying that histone deacetylases contributed to RUNX1-mediated repression.
Maintenance of repression was sensitive to decreased Rpd3 histone deacetylase activity in Drosophila (Wheeler et al., 2002), but the mechanism was unknown. RUNX2 copurified with HDAC6, but not with HDACs 2, 4 and 5, suggesting direct recruitment of this HDAC (Westendorf et al., 2002) . The C-terminal domain of RUNX2 contains a potent repression domain that is also required for association with HDAC6. However, there are HDAC-dependent as well as -independent mechanisms of transcriptional repression, as TSA completely inhibited repression by aa 383-498 of RUNX2 but only partially inhibited repression by aa 383-513 (Westendorf et al., 2002) . This domain was also required for localization of HDAC6 to the chromatin, and HDAC6 coimmunoprecipitated with RUNX2 in osteoblasts where RUNX2 is required for development and differentiation. These data imply that HDAC6 is required for RUNX2-mediated repression and demonstrate a physical interaction between HDAC6 and RUNX2 (Figure 2) .
In order to determine whether RUNX1 could directly associate with histone deacetylases, Cos7 cells were cotransfected with cDNAs encoding RUNX1 and epitope-tagged HDACs1-9 and were immunoprecipitated with antibodies to the tags. RUNX1 associated strongly with HDACs 1, 3 and 9 and weakly with Figure 2 RUNX family members recruit corepressors, HDACs and SUV39H1 to repress transcription. RUNX family members recruit the Groucho homologue TLE to their C-terminal domains that contain the Groucho-binding motif VWRPY. They also associate with the mSin3 corepressors that recruit HDACs 1 and 2. Binding of mSin3 is required for RUNX1-mediated repression of the p21
Waf1/Cip1 promoter in NIH3T3 cells. RUNX1 associates strongly with HDACs 1, 3 and 9 and weakly with HDACs 2, 5 and 6. RUNX2 binds HDAC6. RUNX1 and RUNX3 recruit SUV39H1 to repress transcription. RHD, runt homology domain HDACs 2, 5, and 6 (Durst et al., 2003) (Figure 2 ). These data suggest that HDACs are directly involved in the mechanism of repression by RUNX1 and that RUNX family members recruit distinct HDACs for repression.
RUNX family members are required not only for transcriptional repression, but for gene silencing in Drosophila and mice (Wheeler et al., 2000; Taniuchi et al., 2002) , which has stimulated a search for RUNXrecruited factors that function in long-term gene silencing. SUV39H1 is a histone H3 lysine 9 specific methyltransferase (Rea et al., 2000) . Methylation of lysine 9 of histone H3 is a post-translational modification that allows the binding of heterochromatin protein-1 (HP1) to silence gene expression (Bannister et al., 2001; Lachner et al., 2001; Nakayama et al., 2001) . Coimmunoprecipitation experiments were performed in Cos7 cells cotransfected with cDNAs encoding RUNX1, -2 or -3 and SUV39H1. RUNX1 and RUNX3 associated with SUV39H1 (Reed-Inderbitzen et al., unpublished data). Interestingly, both Runx1 and Runx3 were required for silencing of CD4 during Tcell development (Taniuchi et al., 2002) . However, Runx2 was not required for silencing at the CD4 locus (Taniuchi et al., 2002) and did not associate with SUV39H1 in these assays. In addition, at least one of the SUV39H1 binding domains in RUNX1 is also required for RUNX1-mediated repression of p21 Waf1/Cip1 . Thus, the mechanism of repression by RUNX proteins involves transcriptional corepressors, such as mSin3A, HDACs, and gene silencing factors including SUV39H1 (Figure 2 ).
Contribution of repression domains to translocation fusion proteins in acute leukemia
The chromosomal translocations involving RUNX1 are among the most frequent in human leukemia. These include the t(8:21) that fuses the DNA-binding domain of RUNX1 to the corepressor ETO and the t(12;21) that fuses the N-terminus of TEL to most of RUNX1 (Miyoshi et al., 1991; Erickson et al., 1992; Golub et al., 1995) . In addition, the inv(16) targets the RUNX1 binding partner CBFb and fuses it to the coiled-coil domain of a smooth muscle myosin heavy chain (Liu et al., 1993) . In each of these cases, the fusion protein recruits corepressors and HDACs to create stable, constitutive repression complexes at the promoters of RUNX1 target genes (Gelmetti et al., 1998; Lutterbach et al., 1998; Wang et al., 1998; Fenrick et al., 1999; Guidez et al., 2000; Amann et al., 2001; Wang and Hiebert, 2001; Durst et al., 2003) . The stable association of the fusion proteins with corepressors requires the RUNX1 domains that also contact corepressors. This is especially the case for the t(12;21) fusion protein TEL/ AML1 in which both fusion partners bind to mSin3A, and the resulting fusion protein binds to mSin3A with very high stoichiometry (Fenrick et al., 1999) . Therefore, constitutive repression of RUNX1 target genes, as opposed to the conditional activation or repression by the wild-type RUNX1 protein, appears to contribute to leukemogenesis by the fusion proteins.
Given that DNA-binding transcription factors do not appear to be useful targets for the development of small molecule inhibitors for therapeutic intervention in cancer, RUNX1-associated factors may prove to be useful secondary targets for the development of therapies. The enzymatic activities of HDACs and histone methyltransferases are attractive targets, and HDAC inhibitors such as phenyl butyrate and depsipeptide are already being tested in the clinic. It is possible that these agents will re-activate target genes, including the p14 ARF tumor suppressor (Linggi et al., 2002) , that may cause growth arrest and apoptosis in leukemic cells.
